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Abstract
Aims/hypothesis While the class I phosphoinositide 3-kinases
(PI3Ks) are well-documented positive regulators of metabolism,
the involvement of class II PI3K isoforms (PI3K-C2α, -C2β and
-C2γ) in metabolic regulation is just emerging. Organismal in-
activation of PI3K-C2β increases insulin signalling and sensitiv-
ity, whereas PI3K-C2γ inactivation has a negative metabolic
impact. In contrast, the role of PI3K-C2α in organismal metab-
olism remains unexplored. In this study, we investigated whether
kinase inactivation of PI3K-C2α affects glucose metabolism in
mice.
Methods We have generated and characterised a mouse line
with a constitutive inactivating knock-in (KI) mutation in the
kinase domain of the gene encoding PI3K-C2α (Pik3c2a).
Results While homozygosity for kinase-dead PI3K-C2α was
embryonic lethal, heterozygous PI3K-C2α KI mice were via-
ble and fertile, with no significant histopathological findings.
However, male heterozygous mice showed early onset leptin
resistance, with a defect in leptin signalling in the hypothala-
mus, correlating with a mild, age-dependent obesity, insulin
resistance and glucose intolerance. Insulin signalling was un-
affected in insulin target tissues of PI3K-C2α KI mice, in
contrast to previous reports in which downregulation of
PI3K-C2α in cell lines was shown to dampen insulin signal-
ling. Interestingly, no metabolic phenotypes were detected in
female PI3K-C2α KI mice at any age.
Conclusions/interpretation Our data uncover a sex-dependent
role for PI3K-C2α in the modulation of hypothalamic leptin
action and systemic glucose homeostasis.
Access to research materials All reagents are available upon
request.
Keywords Food intake . Glucose homeostasis . Insulin .
Insulin resistance .Knock-in leptin .Leptin resistance .Mouse
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Introduction
Phosphoinositide 3-kinase (PI3K)s are a family of lipid kinases
that are activated by growth factors, hormones and cytokines,
and which control cell growth, proliferation and metabolism.
Mammals have eight isoforms of PI3K, divided in three classes
[1]. The class I PI3K isoforms (p110α, p110β, p110γ, p110δ)
are activated by tyrosine kinases or G protein-coupled receptors
(GPCRs) and generate the phosphatidylinositol (3,4,5)-tris-
phosphate lipid (also known as PIP3) important for activating
downstream effectors such as Akt/protein kinase B. Among the
class I PI3Ks, p110α has been identified as the most important
isoform in systemic and hepatic insulin signalling [2–4].
In contrast to the class I PI3Ks, the class II (PI3K-C2α, -C2β
and -C2γ) and III (vps34) PI3K isoforms are more enigmatic.
Class II PI3Ks have been reported to be activated by a wide
range of agonists, such as growth factors, GPCRs and adhesion
molecules (reviewed in refs. [1, 5–7]). However, the molecular
details of how class II PI3Ks couple to thismultitude of upstream
receptors remain unclear. Class II PI3Ks are thought to mainly
convert the PI lipid to PI(3)P that is involved in vesicular traf-
ficking processes, such as endocytosis and autophagy. PI(3)P
effectors include proteins containing FYVE or PX lipid-
binding domains. Importantly, class II PI3Ks can also convert
PI(4)P to PI(3,4)P2 [7–10], which, like PIP3, coordinates the
localisation and the function of effector proteins containing a
PH domain.
Previous cell-based studies have revealed non-redundant
functions for the class II PI3K isoforms in a broad variety of
biological processes. For instance, PI3K-C2α has been impli-
cated in the regulation of GLUT4 translocation and glucose
transport, neurosecretory granule release, insulin secretion,
endocytosis and muscle cell contraction, whereas roles for
PI3K-C2β in cell migration and K+ channel activation have
been reported [5, 6, 11].
Knockout (KO) mice for each class II PI3K isoform have
been described. KO studies of the gene encoding PI3K-C2α
(Pik3c2a) have implicated this isoform in angiogenesis [12],
generation of the primary cilium [13] and protection against
kidney cyst formation [14]. Mice homozygous for a gene-trap
Pik3c2a allele resulting in strongly reduced expression of a
carboxy-terminally truncated PI3K-C2α protein, are viable
but develop chronic renal failure [15]. A PI3K-C2β KO
mouse line has been created but no phenotypes have been
reported in these mice to date [16]. More recently, a study
using ΚΟ of PI3K-C2γ, which is mainly expressed in the
liver, has provided evidence that this PI3K isoform is a
Rab5 effector that positively controls insulin signalling in
the liver [10].
In class I PI3K KO mice, remarkable compensation mech-
anisms by the non-targeted isoforms have been reported, with
some class I PI3K KO mice even showing enhanced PI3K
signalling (reviewed in [17]). Such phenomena have not been
observed in class I PI3K mice in which the endogenous PI3K
are inactivated by the introduction of a point mutation in the
kinase domain, so called kinase-dead knock-in (KI) mice
(reviewed in [17]). The KI strategy also better mimics the
impact of systemically administered small molecule inhibitors
of PI3K isoforms.
We recently generated PI3K-C2β kinase-dead KI mice and
showed that this class II PI3K isoform plays a negative role in
insulin signalling and glucose homeostasis [18]. Indeed,
PI3K-C2β ΚΙ mice display enhanced insulin sensitivity and
glucose tolerance, with enhanced insulin-mediated Akt phos-
phorylation [18]. Interestingly, PI3K-C2γ KO mice showed
the inverse phenotype, displaying insulin resistance and glu-
cose intolerance [10].
Given the roles of PI3K-C2β and PI3K-C2γ in glucose me-
tabolism, and the previous evidence from cell line-based studies
for a role for PI3K-C2α in insulin signalling [19–22], we decid-
ed to examine the impact of in vivo PI3K-C2α inactivation on
glucose homeostasis. This was done in heterozygous PI3K-C2α
KI mice, which were viable and fertile, as homozygous inacti-
vation of PI3K-C2α led to embryonic lethality. Unlike in cell
lines, where downregulation of PI3K-C2α has been shown to
dampen insulin signalling, no changes in organismal insulin sen-
sitivity were observed in PI3K-C2α KI young mice. However,
we found that male PI3K-C2α KI mice displayed hypothalamic
leptin resistance, leading to age-dependent obesity, insulin resis-
tance and glucose intolerance.
Methods
Mice Mouse gene targeting was performed by Artemis
(Cologne, Germany) in C57BL/6NT embryonic stem cells.
Mice were backcrossed on the C57BL/6J strain (Charles
River, Margate, UK) for three to five generations.
Pik3c2αtm1521(D1268A)Arte mice used for experiments were on
a mixed C57BL/6J × C57BL/6NT background, with wild-
type (WT) littermates used as controls. Experiments involving
mice were approved by the local ethics committee.
The experimenters were not blind to group assignment and
outcome assessment.
The primers used for genotyping are: forward primer:
1470-29 KI: GACTGATTGGGATACAAACCC, antisense
primer: 1470-30 KI: GCTCTGAGCTGCAGATATGG with
expected fragments: 320 bp (WT), 452 bp (KI), 320 bp
(WT) + 452 bp (KI) under the following PCR conditions:
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95°C for 5 min, 34 times (95°C for 30 s, 60°C for 30 s, 72°C
for 1 min) and 72°C for 10 min.
Lipid kinase assays in vitro PI3K activity assays using
PtdIns as a lipid substrate were performed as described [23].
Western blot analysis and antibodies See electronic
supplementary material (ESM) Methods for further details.
In vivo insulin signalling and other metabolic analyses
were performed as described [18]. Serum levels of leptin were
measured using ELISA kit (Millipore, Billerica, MA, USA).
The pyruvate tolerance test (PTT) was performed by i.p. in-
jection of pyruvate (Sigma-Aldrich, St Louis, MO, USA;
2 g/kg) after an 18 h fast.
Food intake and leptin sensitivity analysisMice were singly
housed and allowed to acclimatise for a week before the study.
Food intake was measured daily and results expressed as cu-
mulative food intake (g of chow). Mice were injected daily
with vehicle (55% 15mmol/l HCl/45% 7.5 mmol/l NaOH, i.p.
vol/vol) for 3 days. After 1 week of recovery, the same mice
were injected daily with leptin (from R&D systems,
Minneapolis, USA; 2.5 mg/kg, i.p.) for 3 days, 2 h before
the onset of the dark cycle. For analysis of leptin signalling
in the hypothalamus, leptin (2 mg/kg) or vehicle were injected
i.p., followed 30 min later by harvesting and freezing of the
hypothalamus in liquid nitrogen. Experiments were performed
on 12-week-old mice.
Histology For tissue sections, haematoxylin and eosin (HE)
staining was performed on 5 μm paraffin sections of tissues
fixed for 16 h in 4% paraformaldehyde (PFA) in PBS at 4°C.
For staining of neutral lipids, cryosections were fixed and
stained with Oil Red O (Sigma-Aldrich). In brief, sections
were fixed with 4% PFA in PBS at room temperature for
15 min. Fixed sections were washed again with PBS and
stained with Oil Red O (0.5% wt/vol. isopropanol, diluted
3:2 in PBS) for 1 h at room temperature. Stained sections were
rinsed in 60% isopropanol, followed by deionised water and
mounted in Vectashield. To randomise the condition of tissue
collection, two cohorts of mice were used for histology of
metabolic tissues. The first set of animals was randomly fed
and perfused with PFA (4%) before collection of the relevant
organs. The second set of mice was starved for 4 h before
tissue sampling.
Determination of adipocyte size To determine the size of
(white) adipocytes, at least 150 adipocytes from representative
sections per fat pad (epididymal and perirenal white adipose
tissue [WAT]) per mouse (four per genotype) were performed
on aMacintosh computer using the public domain NIH Image
J program (developed at the U.S. National Institutes of Health
and available at http://rsb.info.nih.gov/nih-image/) and the
mean value designated as an index of cell size.
HOMA-IR was calculated using glucose and insulin concen-
trations obtained after an 16 h fast, using the following formu-
la: [fasting glucose (mmol/l)× fasting insulin (pmol/l)]/135.
Statistical analysis All data are shown as mean values
±SEM, unless otherwise indicated. Datasets were compared
for statistical significance using the two-tailed Student’s t test
or ANOVAwhere appropriate. Statistical significance is indi-
cated as follows: *p<0.05; **p<0.01; ***p<0.001. The
number of animals in each group is indicated by n. No results
were omitted or excluded from our study.
Results
Generation of PI3K-C2α kinase-dead KI miceWe created
a germline KI mouse line in which the genomic DNA encoding
the ATP-binding DFG motif in the gene encoding PI3K-C2α
(Pik3c2a) is mutated to encode the AFG sequence, resulting in
the production of a kinase-dead PI3K-C2α protein, further re-
ferred to as C2αD1268A (Fig. 1a). Mice heterozygous for the
mutated Pik3c2a allele (hereafter called C2αD1268A/WT
mice; WT indicates the wild-type Pik3c2a allele) were born
at the expected Mendelian ratios, whereas homozygous
C2αD1268A/D1268A embryos could not be recovered beyond
embryonic day 10.5–11.5. This observation is consistent with
the reported lethality of homozygous PI3K-C2α KO embryos
around the same time of development, as a consequence of
impaired vascular angiogenesis [12] and impaired hedgehog
signalling from defective primary cilia [13]. At present, it is
unclear whether the underlying molecular mechanism of le-
thality in the C2αD1268A/D1268A embryos differs from the
PI3K-C2α KO model.
The PI3K-C2α protein showed a broad tissue distribution
with high expression levels in some tissues, including muscle,
WAT, brain, pancreas, spleen, prostate and lung (Fig. 1b). In line
with previous observations using the KI gene targeting strategy,
expression of the kinase-dead PI3K-C2α protein, and that of
other PI3K isoforms, was not significantly altered either in
mouse embryonic fibroblasts (MEFs) derived from E13.5 em-
bryos or in WAT from adult mice (Fig. 1c). PI3K-C2α immu-
noprecipitates from tissues and C2αD1268A/WT MEFs
displayed a ~50% reduction in associated in vitro lipid kinase
activity (Fig. 1d), consistent with heterozygous inactivation of
PI3K-C2α.
Normal glucose homeostasis and insulin sensitivity in
C2αD1268A/WT young mice Heterozygous mice were viable
and fertile, with no apparent defects as assessed by histopatho-
logical analysis of a broad range of tissues of up to 12month-old
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mice (see ESM Table 1]. Class II PI3K overexpression and
RNA interference (RNAi)-based studies in cell lines previously
documented a role for PI3K-C2α in insulin-stimulated glucose
uptake [24] and insulin secretion [25, 26]. Therefore, we first
monitored metabolic variables in C2αD1268A/WT mice. Levels
of blood glucose (Fig. 2a–d) and plasma insulin (Fig. 2e–h) in
overnight-fasted or randomly fed states were unaffected in both
12-week-old C2αD1268A/WT male and female mice, although a
slight hyperglycaemia and a tendency to hyperinsulinaemia was
observed in male mice under fed conditions (Fig. 2c, g). Overall
glucose clearance upon injection of glucose (Fig. 2i, j) or insulin
(Fig. 2k, l) was not significantly affected in mice of both sexes
(no statistically significant differences in the AUCs), although a
mild (but statistically non-significant) tendency for improvement
of glucose and insulin tolerance was observed in female mice
(Fig. 2j, l).
In line with the lack of metabolic defects, phosphorylation
of Akt in liver, muscle and fat was similar in 12-week-old WT
and C2αD1268A/WT mice upon insulin injection (ESM Fig. 1a
and data not shown). These data indicate that organismal glu-
cose homeostasis and insulin signalling are not critically de-
pendent on PI3K-C2α activity.
Increased leptin levels and leptin resistance in male
C2αD1268A/WT mice Although daily food consumption was
not significantly affected, cumulative food intake was en-
hanced over a period of 7 days (data not shown) and 28 days
in male (Fig. 3a) but not in female mice (data not shown).
Leptin, an adipose-derived hormone, is known to suppress
appetite by interacting with the leptin receptor (LEPRb) in
the hypothalamus [27, 28]. Circulating levels of leptin were
approximately 25% higher in both young (12 weeks) and old
(32 weeks) male C2αD1268A/WT mice compared with WT
mice (Fig. 3b, d), with no changes in female C2αD1268A/WT
mice (Fig. 3c, e). For this reason, we focused further investi-
gations only on male mice.
In addition to leptin’s well-known sexual dimorphism, with
males known to bemore sensitive to leptin than females [29, 30],
body adiposity plays a crucial role in modulating leptin levels
[29]. We found that, in young male C2αD1268A/WT mice, the
body weight was unaffected compared with WT mice
(Fig. 3f), with no changes in different organ weight (including
WAT) apart from a slight reduction of the kidney weight (ESM
Fig. 1b–f). In addition, no significant histopathological findings
were observed in HE-stained kidneys (data not shown). These
data show that the increased leptinaemia does not result from
increased adiposity.
As a consequence, the higher levels of circulating leptin
most likely arose as a compensatory mechanism for leptin
resistance [31]. Indeed, in response to injection of leptin,
hypothalami from young (12-week-old) male C2αD1268A/WT
mice showed markedly reduced phosphorylation of Stat3, a
downstream effector of leptin (Fig. 3g). In line with these
observations, systemically administered leptin had a severely
reduced ability to acutely reduce food intake in C2αD1268A/WT
male mice, compared with WT mice (Fig. 3h). As expected,
the hypothalamic response to leptin injection was unaffected
in female C2αD1268A/WT mice (ESM Fig. 1g). Taken together,
these results demonstrate that hypothalamic leptin signalling
is defective in young (12-week-old) male C2αD1268A/WTmice,
giving rise to an early onset leptin resistance.
Age-dependent obesity in male C2αD1268A/WT mice Mice
and humans with leptin-deficiency (ob/ob) or leptin resistance
(db/db) are obese and hyperphagic [27, 31–35]. Accordingly,
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Fig. 1 Generation and characterisation of C2αD1268A/WT KI mice. (a)
Gene targeting strategy to introduce the D1268A mutation in the DFG
motif in exon 24 of the Pik3c2a gene. The FRT-flanked cassette encoding
the Pgk Neo selection marker was removed in vivo by breeding onto
ACTB-Flp mice. (b) PI3K-C2α protein expression. Tissue homogenates
were analysed by SDS–PAGE and immunoblotting using anti-PI3K-C2α
antibody. (c) PI3K isoform expression inWTand C2αD1268A/WTcells and
tissue. Each lane on the SDS–PAGE gel represents an independent
mouse. Homogenates of MEFs or epididymalWAT frommale mice were
analysed by SDS–PAGE and immunoblotting using the indicated anti-
bodies. (d) Lipid kinase activity associated with PI3K-C2α in WT and
C2αD1268A/WT mice. Homogenates of MEFs or epididymal WAT from
male mice were immunoprecipitated using PI3K-C2α antibody, and sub-
jected to an in vitro PI3K activity assay. Results shown are pooled data
from three independent experiments (each with 2–4 experimental repli-
cates). *p< 0.05; ***p< 0.001
1506 Diabetologia (2016) 59:1503–1512
and in line with the elevated cumulative food intake, male
C2αD1268A/WT mice displayed a mild, adult-onset obesity under
normal chow diet. Male C2αD1268A/WT mice showed a similar
body weight toWTmice until 21 weeks of age and reach a 12%
increase in body weight compared withWTmice at 32 weeks of
age (Fig. 4a–e). In line with their normal circulating levels of
leptin (Fig. 3c, e), female C2αD1268A/WTmice exhibited a similar
weight gain to WT mice (ESM Fig. 1h).
We next investigated the weight gain phenotype in male mice
in more detail. Nose-to-tail length was unaffected in both male
and female C2αD1268A/WT mice (data not shown), suggesting
that the weight gain observed was not due to increased animal
growth. Thirty-two-week-old male C2αD1268A/WT mice
displayed increased adiposity (Fig. 4f) and loss of relativemuscle
mass (Fig. 4g, h). Histological analysis, confirmed by consistent
sampling and using robust morphometric analysis, revealed en-
larged adipose cells in epididymal (Fig. 4i–k) and perirenalWAT
(ESM Fig. 1i–k) in 50% of the C2αD1268A/WT mice analysed.
Consistent with the development of obesity, more than half of the
male C2αD1268A/WT mice had increased lipid accumulation in
the liver, as assessed byHE staining (hepatocellular vacuolation),
and enhanced Oil Red O staining (Fig. 4l).
Taken together, these data indicate that the leptin resistance
observed in male C2αD1268A/WT mice is accompanied by age-
dependent obesity, with an increase in adipose tissue and en-
hanced hepatic lipid accumulation.
Hyperglycaemia and insulin resistance in obese male
C2αD1268A/WT mice We next assessed the impact of the
late-onset obesity on glucose homeostasis and insulin sensi-
tivity. Under fed, but not under fasted conditions, 32-week-old
C2αD1268A/WT males displayed hyperglycaemia (Fig. 5a, b)
and hyperinsulinaemia (Fig. 5c, d), with reduced glucose
clearance, despite an observed elevated insulin secretion dur-
ing the glucose tolerance test (GTT) (Fig. 5e, f). This was
correlated with insulin resistance, as observed during the in-
sulin tolerance test (ITT) (Fig. 5g). We quantified insulin resis-
tance by calculating the HOMA-IR index. Thirty-two-week-old
C2αD1268A/WT male mice showed an increase in the HOMA-IR
index (Fig. 5h), which correlated with the impaired insulin sen-
sitivity observed in these mice compared with WT. In line with
their normal leptinaemia (Fig. 3c, e) and weight gain (ESM
Fig. 1h), female C2αD1268A/WT mice exhibited similar
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glycaemia, insulinaemia and glucose clearance during GTT or
ITT as WT mice (ESM Fig. 2a–f).
Unexpectedly, 32-week-old C2αD1268A/WT and WT mice
showed similar levels of insulin-induced Akt phosphorylation
in the liver, muscle and adipose tissue (Fig. 5i). Moreover, a
PTT (ESM Fig. 2g) displayed no differences between the
C2αD1268A/WT and WT mice indicating that gluconeogenesis
from pyruvate was unaffected in C2αD1268A/WT mice.
Discussion
In order to assess the role of the kinase activity of the class II
PI3K-C2α, we created a mouse model in which this PI3K iso-
form has been rendered inactive by introduction of a germlineKI
mutation in the conserved DFG motif of the ATP-binding site.
Recently this mouse model facilitated the uncovering of a new
role of PI3K-C2α in platelet membrane morphology [36].
The roles of the class I PI3Ks on metabolism and energy
homeostasis have been well-documented [2–4, 23, 37].
Recently, PI3K-C2β and PI3K-C2γ were shown to play a role
in glucose metabolism and insulin signalling in vivo [10, 18],
with no in vivo metabolic phenotypes of PI3K-C2α reported to
date. In the present study, we examined the role of PI3K-C2α
in whole-body insulin sensitivity and glucose homeostasis.
Our data reveal that systemic ablation of half of the activity
of PI3K-C2α induces leptin resistance in male mice, with a
primary defect in leptin signalling in the hypothalamus.
Despite normal body weight and adiposity, young
C2αD1268A/WT mice had higher circulating leptin levels than
WT littermates, and displayed mild hyperphagia. Partial inac-
tivation of PI3K-C2α dampened the reduction in food intake
upon exogenous leptin injection, and impaired hypothalamic
leptin signalling. In line with this defective leptin responsive-
ness, partial inactivation of PI3K-C2α led to the development
of adult-onset obesity, with accompanying hypertrophy of the
adipose tissue, abnormal hepatic lipid accumulation, glucose
intolerance, hyperinsulinaemia and insulin resistance. The de-
velopment of these defects upon ageing was not the result of
an intrinsic defect in insulin signalling in insulin-sensitive tis-
sues (WAT, liver and skeletal muscle), as indicated by unal-
tered insulin-induced phosphorylation of Akt. In addition to
the mild hyperphagia observed in C2αD1268A/WT mice, we
cannot rule out a possible role of PI3K-C2α inactivation in
reducing energy expenditure in the development of the ob-
served age-onset obesity.
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PI3K-C2α in insulin signalling and secretion Our data
show that in vivo, full PI3K-C2α activity is not required for
insulin signalling at any stage of adult development. Indeed,
young C2αD1268A/WT mice displayed normal insulin signalling
in all tissues tested and, as a result, had unaffected systemic
insulin sensitivity and glucose tolerance. These observations are
in sharp contrast with the previous cell-based studies that report-
ed a positive role for PI3K-C2α in insulin signalling, glucose
uptake and insulin secretion [24–26]. The reason for these dis-
crepancies is unclear at the moment. While it is conceivable that
data obtained in tissue culture cells do not translate to primary
tissues, it is also possible that a more substantial inhibition of
PI3K-C2α than heterozygous inactivation is required to interfere
with insulin signalling. All KI mice heterozygous for a kinase-
dead allele that we have generated thus far, including PI3K-C2α
KImice [36] have been found to display defects in signalling and
other phenotypes (p110α: [2, 38]; p110β: [39]; p110δ: [40, 41]).
We have also observed metabolic phenotypes in heterozygous
PI3K-C2β and vps34 KI mice (our unpublished results). These
phenotypes are especially detectable at non-saturating doses of
stimulus (including insulin signalling in the case of p110α [2]).
We therefore expected the KI gene targeting strategy applied to
PI3K-C2α to give rise to partial, stimulus dose-dependent phe-
notypes, but it is possible that a more substantial (>50%) inhibi-
tion of PI3K-C2α might be required to interfere with the
biological responses investigated. It is important to mention that
the previously reported cell-based studies made use of
PI3K-C2α RNAi and overexpression strategies which affect
both the kinase activity (as in the current study) as well as po-
tential scaffolding functions of PI3K-C2α [17].
Interestingly, at old age, male C2αD1268A/WTmice did display
glucose intolerance and insulin resistance, greatly contrasting the
unaltered insulin signalling observed in insulin-sensitive tissues.
As mentioned above, it is possible that a more substantial inhi-
bition of PI3K-C2α (>50% inhibition) is required to interfere
with insulin signalling.
PI3K-C2α in leptin signallingOur data show that PI3K-C2α
activity is critical for leptin signalling in the brain. Interestingly,
a previous study has presented evidence for leptin-induced ac-
tivation of PI3K-C2α in macrophages [42]. In addition to ac-
tions in the brain, leptin also directly acts on multiple peripheral
tissues, including pancreatic islets, liver, adipose tissue, kidney
and skeletal muscle [43, 44]. However, genetic deletion of the
leptin receptor in these tissues does not alter energy balance,
body weight or glucose homeostasis [43, 44], highlighting a
more critical role for leptin signalling in the brain with regards
to organismal metabolism.
Leptin has also been shown to play an important role in
renal pathophysiology [45, 46]. Despite a small decrease in
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the relative weight of the kidneys in aged C2αD1268A/WT male
mice in relation to overall body weight, we did not observe
any histopathological abnormalities in the kidneys of male or
female heterozygous C2αD1268A/WT mice. However, previ-
ously described PI3K-C2α gene-trap mice, which have
>75% reduction in organismal PI3K-C2α activity, develop
chronic renal failure and a range of kidney lesions, even at a
young age [15]. It would be interesting to assess whether a
metabolic phenotype is also observed in PI3K-C2α gene-trap
mice and whether leptin resistance in kidney cells could con-
tribute to their kidney phenotype.
Finally, the sexual dimorphism of the leptin resistance phe-
notype in the C2αD1268A/WT mice is in line with the known
sexual dimorphism in leptin biology in rodents or humans at
the level of serum leptin levels, leptin receptor expression and
signalling [29]. Indeed, serum leptin and receptor levels are
significantly higher in female mice than in male with
equivalent body fat mass [30], which might render females
less sensitive to dysfunctions in leptin signalling.
It is most likely that the increase in leptin levels observed in
male C2αD1268A/WTmice is a consequence of a hypothalam-
ic leptin resistance, with the adipose tissue (which is not
increased in size at young age) secreting more leptin to
compensate for the decrease in leptin signalling in the hy-
pothalamus. However, we cannot exclude the possibility
that PI3K-C2α could also be involved in leptin secretion
from the WAT.
At present, the mechanism of leptin resistance in the male
C2αD1268A/WT mice is unclear. Leptin resistance can be due to
a multitude of mechanisms, including defective leptin transport
from the blood circulation to the brain, defective hypothalamic
neural circuitry that regulates energy homeostasis and/or al-
tered leptin signalling [44]. Leptin-induced Stat3 phosphoryla-
tion was found to be reduced in the hypothalamus in
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C2αD1268A/WT mice, indicating that the defect occurs at the
level of LEPR signalling. PI(3)P and PI(3,4)P2 are lipid prod-
ucts of PI3K-C2α that have been implicated in intracellular
vesicular transport, including endocytosis and exocytosis [5,
6]. Importantly, PI3K-C2α has been shown to be concentrated
in the trans-Golgi network [47]. It is therefore tempting to spec-
ulate that PI3K-C2α is involved in LEPR trafficking. LEPRb,
the functional isoform of the leptin receptor, mainly resides in
the trans-Golgi network and endosomes, with only a relatively
small number of receptors on the plasma membrane to medi-
ate leptin signalling [44]. Interestingly, deletion of Bardet-
Biedl syndrome (BBS) proteins, known to promote LEPRb
trafficking, impairs leptin signalling and results in leptin resis-
tance and obesity, both in mouse models and in humans
[48–50]. In addition to regulating LEPRb trafficking,
BBS proteins also play a critical role in the regulation
of cilia length as shown in renal medullary cells [51]. In
these cells, inactivation of BBS proteins leads to shorter
cilia, a phenotype also observed in PI3K-C2α heterozy-
gote KO mice [14]. Cilia are important cellular structures
that regulate signalling cascades that affect feeding and
satiety [52] but are not directly involved in leptin signal-
ling [53]. Conversely, leptin levels have been shown to
regulate neuronal cilia length [52]. Altogether, these data
point to a potential role for BBS proteins downstream of
PI3K-C2α, impacting both on leptin signalling and cilia
length, which could directly and indirectly, respectively,
affect organismal metabolism.
In summary, our studies describe the phenotypic character-
isation of the first mouse model with a kinase-dead PI3K-C2α
and reveal a role for this PI3K in organismal leptin signalling
and age-dependent regulation of glucose homeostasis in
males.
Acknowledgements We thank D. Withers (Imperial College London,
UK), M. Whitehead (UCL, London, UK), E. Aksoy (Queen Mary
University of London, UK), S. Taboubi (UCL, London, UK) and M.
Walsh (Wellcome Trust, London, UK) for feedback and discussions.
Funding Personal support was from EU Marie Curie (to SA [PIEF-
GA-2009-252916] and CC [PIIF-GA-2009-252846]) and EMBO to SA
(ALTF 753-2010). Work in the BV laboratory was supported by the
BBSRC (BB/I007806/1) and the Ludwig Institute for Cancer Research.
Duality of interest The authors declare that there is no duality of inter-
est associated with this manuscript. None of the authors of thismanuscript
have a financial interest related to this work. BV is a consultant for Karus
Therapeutics (Oxford, UK).
Contribution statement SA, BB, CC and BV were the main contrib-
utors in the conception, design, acquisition and interpretation of the data
and in writing the manuscript. SA, BB, CC, WP, LSM, LCF and CLS
performed experiments, data analysis and revised the manuscript. All
authors approved the final version of the manuscript. CC and BV are
responsible for the integrity of the work as a whole.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B
(2010) The emerging mechanisms of isoform-specific PI3K signal-
ling. Nat Rev Mol Cell Biol 11:329–341
2. Foukas LC, Claret M, Pearce W et al (2006) Critical role for the
p110alpha phosphoinositide-3-OH kinase in growth and metabolic
regulation. Nature 441:366–370
3. Knight ZA, Gonzalez B, Feldman ME et al (2006) A pharmacolog-
ical map of the PI3-K family defines a role for p110alpha in insulin
signaling. Cell 125:733–747
4. Sopasakis VR, Liu P, Suzuki R et al (2010) Specific roles of the
p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic in-
sulin signaling and metabolic regulation. Cell Metab 11:220–230
5. Falasca M, Maffucci T (2012) Regulation and cellular functions of
class II phosphoinositide 3-kinases. Biochem J 443:587–601
6. Jean S, Kiger AA (2014) Classes of phosphoinositide 3-kinases at a
glance. J Cell Sci 127:923–928
7. Campa CC, Franco I, Hirsch E (2015) PI3K-C2alpha: one enzyme
for two products coupling vesicle trafficking and signal transduc-
tion. FEBS Lett 589:1552–1558
8. Nigorikawa K, Hazeki K, Guo Y, Hazeki O (2014) Involvement of
class II phosphoinositide 3-kinase alpha-isoform in antigen-induced
degranulation in RBL-2H3 cells. PLoS One 9, e111698
9. Posor Y, Eichhorn-Gruenig M, Puchkov D et al (2013)
Spatiotemporal control of endocytosis by phosphatidylinositol-3,
4-bisphosphate. Nature 499:233–237
10. Braccini L, Ciraolo E, Campa CC et al (2015) PI3K-C2gamma is a
Rab5 effector selectively controlling endosomal Akt2 activation
downstream of insulin signalling. Nat Commun 6:7400
11. Kitatani K, Usui T, Sriraman SK et al (2015) Ceramide limits
phosphatidylinositol-3-kinase C2beta-controlled cell motility in
ovarian cancer: potential of ceramide as a metastasis-suppressor
lipid. Oncogene. doi:10.1038/onc.2015.330
12. Yoshioka K, Yoshida K, Cui H et al (2012) Endothelial PI3K-
C2alpha, a class II PI3K, has an essential role in angiogenesis and
vascular barrier function. Nat Med 18:1560–1569
13. Franco I, Gulluni F, Campa CC et al (2014) PI3K class II alpha
controls spatially restricted endosomal PtdIns3P and Rab11 activa-
tion to promote primary cilium function. Dev Cell 28:647–658
14. Franco I, Margaria JP, De Santis MC et al (2015) Phosphoinositide
3-kinase-C2alpha regulates polycystin-2 ciliary entry and protects
against kidney cyst formation. J Am Soc Nephrol JASN. doi:10.
1681/ASN.2012111089
15. Harris DP, Vogel P, Wims M et al (2011) Requirement for class II
phosphoinositide 3-kinase C2alpha in maintenance of glomerular
structure and function. Mol Cell Biol 31:63–80
16. Harada K, Truong AB, Cai T, Khavari PA (2005) The class II
phosphoinositide 3-kinase C2beta is not essential for epidermal
differentiation. Mol Cell Biol 25:11122–11130
17. Vanhaesebroeck B, Ali K, Bilancio A, Geering B, Foukas LC
(2005) Signalling by PI3K isoforms: insights from gene-targeted
mice. Trends Biochem Sci 30:194–204
18. Alliouachene S, Bilanges B, ChicanneG et al (2015) Inactivation of
the class II PI3K-C2beta potentiates insulin signaling and sensitiv-
ity. Cell Rep 13:1881–1894
Diabetologia (2016) 59:1503–1512 1511
19. Brown RA, Domin J, Arcaro A, Waterfield MD, Shepherd PR (1999)
Insulin activates the alpha isoform of class II phosphoinositide 3-ki-
nase. J Biol Chem 274:14529–14532
20. Urso B, Brown RA, O'Rahilly S, Shepherd PR, Siddle K
(1999) The alpha-isoform of class II phosphoinositide 3-kinase
is more effectively activated by insulin receptors than IGF re-
ceptors, and activation requires receptor NPEY motifs. FEBS
Lett 460:423–426
21. Soos MA, Jensen J, Brown RA, O'Rahilly S, Shepherd PR,
Whitehead JP (2001) Class II phosphoinositide 3-kinase is
activated by insulin but not by contraction in skeletal mus-
cle. Arch Biochem Biophys 396:244–248
22. Leibiger B,Moede T, PaschenM et al (2015) PI3K-C2alpha knock-
down results in rerouting of insulin signaling and pancreatic beta
cell proliferation. Cell Rep 13:15–22
23. Chaussade C, Rewcastle GW, Kendall JD et al (2007) Evidence for
functional redundancy of class IA PI3K isoforms in insulin signal-
ling. Biochem J 404:449–458
24. Falasca M, Hughes WE, Dominguez V et al (2007) The role of
phosphoinositide 3-kinase C2alpha in insulin signaling. J Biol
Chem 282:28226–28236
25. Dominguez V, Raimondi C, Somanath S et al (2011) Class II
phosphoinositide 3-kinase regulates exocytosis of insulin granules
in pancreatic beta cells. J Biol Chem 286:4216–4225
26. Leibiger B, Moede T, Uhles S et al (2010) Insulin-feedback via
PI3K-C2alpha activated PKBalpha/Akt1 is required for glucose-
stimulated insulin secretion. FASEB J 24:1824–1837
27. Lee GH, Proenca R, Montez JM et al (1996) Abnormal splicing of
the leptin receptor in diabetic mice. Nature 379:632–635
28. Tartaglia LA, Dembski M, Weng X et al (1995) Identification and
expression cloning of a leptin receptor, OB-R. Cell 83:1263–1271
29. Considine RV (2001) Regulation of leptin production. Rev Endocr
Metab Disord 2:357–363
30. Guerra B, Fuentes T, Delgado-Guerra S et al (2008) Gender dimor-
phism in skeletal muscle leptin receptors, serum leptin and insulin
sensitivity. PLoS One 3, e3466
31. Maffei M, Halaas J, Ravussin E et al (1995) Leptin levels in human
and rodent: measurement of plasma leptin and ob RNA in obese
and weight-reduced subjects. Nat Med 1:1155–1161
32. Chen H, Charlat O, Tartaglia LA et al (1996) Evidence that the
diabetes gene encodes the leptin receptor: identification of a muta-
tion in the leptin receptor gene in db/db mice. Cell 84:491–495
33. Chua SC Jr, Chung WK, Wu-Peng XS et al (1996) Phenotypes of
mouse diabetes and rat fatty due to mutations in the OB (leptin)
receptor. Science (New York, NY) 271:994–996
34. Farooqi S, O'Rahilly S (2006) Genetics of obesity in humans.
Endocr Rev 27:710–718
35. Montague CT, Farooqi IS, Whitehead JP et al (1997) Congenital
leptin deficiency is associated with severe early-onset obesity in
humans. Nature 387:903–908
36. Valet C, ChicanneG, Severac C et al (2015) Essential role of class II
PI3K-C2alpha in platelet membrane morphology. Blood 126:1128–
1137
37. Al-Qassab H, Smith MA, Irvine EE et al (2009) Dominant role of
the p110beta isoform of PI3K over p110alpha in energy homeosta-
sis regulation by POMC and AgRP neurons. Cell Metab 10:343–
354
38. Graupera M, Guillermet-Guibert J, Foukas LC et al (2008)
Angiogenesis selectively requires the p110alpha isoform of PI3K
to control endothelial cell migration. Nature 453:662–666
39. Guillermet-Guibert J, Bjorklof K, Salpekar A et al (2008) The
p110beta isoform of phosphoinositide 3-kinase signals downstream
of G protein-coupled receptors and is functionally redundant with
p110gamma. Proc Natl Acad Sci U S A 105:8292–8297
40. Okkenhaug K, Bilancio A, Farjot G et al (2002) Impaired B and T
cell antigen receptor signaling in p110delta PI 3-kinase mutant
mice. Science (New York, NY) 297:1031–1034
41. Bilancio A, Okkenhaug K, Camps M et al (2006) Key role of the
p110delta isoform of PI3K in B cell antigen and IL-4 receptor
signaling: comparative analysis of genetic and pharmacologic inter-
ference with p110delta function in B cells. Blood 107:642–650
42. Ktori C, Shepherd PR, O'Rourke L (2003) TNF-alpha and leptin
activate the alpha-isoform of class II phosphoinositide 3-kinase.
Biochem Biophys Res Commun 306:139–143
43. Guo K,McMinn JE, Ludwig Tet al (2007) Disruption of peripheral
leptin signaling in mice results in hyperleptinemia without associ-
ated metabolic abnormalities. Endocrinology 148:3987–3997
44. Morris DL, Rui L (2009) Recent advances in understanding leptin
signaling and leptin resistance. Am J Physiol Endocrinol Metab
297:E1247–E1259
45. Sharma K, McCue P, Dunn SR (2003) Diabetic kidney disease in
the db/db mouse. Am J Physiol Renal Physiol 284:F1138–F1144
46. Wolf G, Ziyadeh FN (2006) Leptin and renal fibrosis. Contrib
Nephrol 151:175–183
47. Domin J, Gaidarov I, Smith ME, Keen JH, Waterfield MD (2000)
The class II phosphoinositide 3-kinase PI3K-C2alpha is concentrat-
ed in the trans-Golgi network and present in clathrin-coated vesi-
cles. J Biol Chem 275:11943–11950
48. Rahmouni K, Fath MA, Seo S et al (2008) Leptin resistance con-
tributes to obesity and hypertension in mouse models of Bardet-
Biedl syndrome. J Clin Invest 118:1458–1467
49. Seo S, Guo DF, Bugge K, Morgan DA, Rahmouni K, Sheffield VC
(2009) Requirement of Bardet-Biedl syndrome proteins for leptin
receptor signaling. Hum Mol Genet 18:1323–1331
50. Feuillan PP, Ng D, Han JC et al (2011) Patients with Bardet-Biedl
syndrome have hyperleptinemia suggestive of leptin resistance.
J Clin Endocrinol Metab 96:E528–E535
51. Hernandez-Hernandez V, Pravincumar P, Diaz-Font A et al (2013)
Bardet-Biedl syndrome proteins control the cilia length through
regulation of actin polymerization. Hum Mol Genet 22:3858–3868
52. Han YM, Kang GM, Byun K et al (2014) Leptin-promoted cilia
assembly is critical for normal energy balance. J Clin Invest 124:
2193–2197
53. Berbari NF, Pasek RC, Malarkey EB et al (2013) Leptin resistance
is a secondary consequence of the obesity in ciliopathy mutant
mice. Proc Natl Acad Sci U S A 110:7796–7801
1512 Diabetologia (2016) 59:1503–1512
